• Geneticin, G-418 Sulfate: Selection Guide

  2026-09-08

  Geneticin, G-418 Sulfate is a water-soluble aminoglycoside used to select and maintain cells expressing the neomycin resistance gene, with an additional dossier-described application in Dengue virus research. It should be titrated for each cell line and is not suitable for workflows that require ethanol or DMSO solubility or that assume antiviral activity will transfer across cell types and viruses.

• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-09-08

  The reference study identifies a Rab11a/Rab11FIP1 trafficking mechanism through which lithium increases exosomal Wnt10a secretion from bone mesenchymal stem cells and activates Wnt/β-catenin signaling. Its comparison of lithium-conditioned exosomes and untreated exosomes, followed by GelMA hydrogel delivery, provides a mechanistic and translational framework for improving bone repair.

• Ceftolozane Sulfate: Assay and PK/PD Workflows

  2026-09-07

  Ceftolozane sulfate supports resistance-aware susceptibility testing, dynamic time-kill experiments, and translational PK/PD studies focused on Pseudomonas aeruginosa and selected Enterobacterales. This workflow separates standalone ceftolozane activity from combination-drug effects while adding practical controls for concentration, inoculum, storage, and resistance interpretation.

• SVA 3A/2B–DDX23 Antiviral Defense

  2026-09-07

  Li et al. describe a bidirectional host–virus interaction in which DDX23 restricts Senecavirus A through caspase-dependent degradation of viral 3A, while viral 2B promotes caspase-mediated loss of DDX23. The study combines expression perturbation, caspase inhibitor experiments, residue analysis, and recombinant viruses to identify amino acids that regulate this antiviral conflict.

• Peroxynitrite, Ca2+ Flux, and HHcy Cardiac I/R

  2026-09-05

  Liu et al. identify a mechanistic chain linking hyperhomocysteinemia to cardiac microvascular ischemia–reperfusion injury: peroxynitrite-driven ER stress increases IP3R-dependent Ca2+ transfer to mitochondria, producing mitochondrial overload and CMEC necroptosis. The findings position ER–mitochondrial Ca2+ handling as a potential intervention point while providing a framework for mechanistic necroptosis assay design.

• ATRX Loss Sensitizes Glioma to RTK Inhibitors

  2026-09-04

  Pladevall-Morera and colleagues identified a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells were more sensitive to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. The study also found pronounced toxicity when RTK inhibition was combined with temozolomide, supporting ATRX status as a relevant biomarker for interpreting targeted-therapy studies in glioma.

• Losartan: AT1 Signaling to Phenotype

  2026-09-04

  Losartan is an angiotensin II receptor antagonist for dissecting AT1-driven vascular phenotypes. This guide connects receptor-level perturbation with rigorous assay design and interprets a macrophage SPP1 screening study without overstating cross-domain evidence.

• Medroxyprogesterone Acetate: From Receptor to Translation

  2026-09-03

  Medroxyprogesterone acetate is more than a progesterone-receptor agonist. By connecting receptor context with renal, neural, and endometrial metabolism, translational researchers can design MPA studies that are more mechanistically resolved and reproducible.

• Zosuquidar and the Next Wave of MDR Resistance Biology

  2026-09-03

  Zosuquidar (LY335979) reframes P-glycoprotein inhibition as more than a chemotherapy-sensitization tactic. Emerging evidence links ABCB1-mediated efflux to acquired resistance against targeted PROTAC degraders, creating a translational strategy for distinguishing target mutation from transporter-driven treatment failure.

• Cardamomin, Oxidative Damage, and Ischemic Stroke

  2026-09-02

  This study connects cardamomin from Amomum villosum stems and leaves with protection against hydrogen peroxide-induced oxidative damage in BV-2 cells and injury in a rat permanent middle cerebral artery occlusion model. Its main mechanistic contribution is the integration of MEK/ERK-dependent NRF2 activation with suppression of AIFM1-associated oxeiptosis and parthanatos, while TTC staining provides a tissue-level outcome measure.

• Glutamine Metabolism in HSCs and Liver Fibrosis

  2026-09-02

  Yin et al. show that glutamine catabolism sustains hepatic stellate cell activation and that the mitochondrial regulator SIRT4 can suppress this process by restraining GDH activity. The study connects SIRT4, GDH, α-ketoglutarate production, and fibrotic progression, suggesting a metabolic strategy for limiting liver fibrosis while highlighting important translational uncertainties.

• Tropisetron Hydrochloride: Receptor & Transporter Guide

  2026-09-01

  Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist used to investigate serotonin 5-HT3 receptor pathway biology and related transporter effects. Supplier-reported potency, solubility, identity, and storage specifications support controlled neuroscience receptor modulation and in vitro pharmacology workflows.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-09-01

  A 2025 study used network proximity analysis to screen flavonoids against Alzheimer’s disease-associated targets and identified Apigenin as the strongest candidate among four experimentally tested compounds. Cellular validation linked its neuroprotective activity to preservation of mitochondrial function, reduced apoptosis, AKT/NF-κB pathway modulation, and regulation of microglial inflammatory states.

• Bortezomib (PS-341) as a Proteostasis Probe

  2026-08-31

  Bortezomib (PS-341) is more than a cytotoxic control: it can help distinguish proteasome-dependent stress from autophagic protein clearance in cancer assays. This guide translates FOXM1 pathway findings into a rigorous experimental framework for apoptosis, proteostasis, and drug-resistance research.

• Geneticin in Cell Selection and Metabolic Assays

  2026-08-31

  Geneticin is more than a selection reagent: its translation-blocking activity can influence the metabolic phenotypes measured in engineered cells. This guide connects G418 selection with glutamine-metabolism studies in hepatic stellate cells, emphasizing assay design, controls, and interpretation.

8081 records 1/539 page Next 12345 下5页 Last page